{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:18:43Z","timestamp":1787847523378,"version":"build-2784847793"},"reference-count":127,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cpcardiol.2025.103148","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T01:58:18Z","timestamp":1754618298000},"page":"103148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Revisiting type 2 myocardial infarction: Unmet clinical needs"],"prefix":"10.1016","volume":"50","author":[{"given":"Andrea","family":"Palermi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Saraullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Bernadette","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Gallina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4770-8386","authenticated-orcid":false,"given":"Giulia","family":"Renda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.cpcardiol.2025.103148_bib0001","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart. J."},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103148_bib0002","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur. Heart. J."},{"issue":"22","key":"10.1016\/j.cpcardiol.2025.103148_bib0003","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1161\/CIRCULATIONAHA.119.042157","article-title":"A proposal for modest revision of the definition of type 1 and type 2 myocardial infarction","volume":"140","author":"De Lemos","year":"2019","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103148_bib0004","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1038\/s41591-023-02513-2","article-title":"A new clinical classification of acute myocardial infarction","volume":"29","author":"Lindahl","year":"2023","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.cpcardiol.2025.103148_bib0005","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/CIRCULATIONAHA.117.031806","article-title":"Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury","volume":"137","author":"Chapman","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103148_bib0006","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/clinchem\/hvaa189","article-title":"Type 2 myocardial infarction: evolving approaches to diagnosis and risk-stratification","volume":"67","author":"Chapman","year":"2021","journal-title":"Clin. Chem."},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103148_bib0007","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jacc.2020.12.034","article-title":"Patient characteristics and clinical outcomes of type 1 versus type 2 myocardial infarction","volume":"77","author":"McCarthy","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103148_bib0008","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.5853","article-title":"Application of the Universal definition of myocardial infarction in clinical practice in Scotland and Sweden","volume":"7","author":"Taggart","year":"2024","journal-title":"JAMa Netw. Open."},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103148_bib0009","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/14017431.2019.1638961","article-title":"Diagnosing type 2 myocardial infarction in clinical routine. A validation study","volume":"53","author":"Gard","year":"2019","journal-title":"Scand. Cardiovasc. J."},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103148_bib0010","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1038\/s41598-023-34312-7","article-title":"Management and outcome trends in type 2 myocardial infarction: an investigation from the SWEDEHEART registry","volume":"13","author":"Eggers","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cpcardiol.2025.103148_bib0011","doi-asserted-by":"crossref","first-page":"e03","DOI":"10.15420\/ecr.2021.42","article-title":"Type 2 MI and myocardial injury in the era of high-sensitivity troponin","volume":"17","author":"Rafiudeen","year":"2022","journal-title":"Eur. Cardiol. Rev."},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103148_bib0012","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/eurheartj\/ehab581","article-title":"Risk factors for type 1 and type 2 myocardial infarction","volume":"43","author":"Wereski","year":"2022","journal-title":"Eur. Heart. J."},{"issue":"47","key":"10.1016\/j.cpcardiol.2025.103148_bib0013","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1093\/eurheartj\/ehx457","article-title":"Discrimination of patients with type 2 myocardial infarction","volume":"38","author":"Neumann","year":"2017","journal-title":"Eur. Heart. J."},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103148_bib0014","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/CIRCULATIONAHA.116.023052","article-title":"Incident type 2 myocardial infarction in a cohort of patients undergoing coronary or peripheral arterial angiography","volume":"135","author":"Gaggin","year":"2017","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.cpcardiol.2025.103148_bib0015","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1136\/heartjnl-2021-319118","article-title":"Sex differences in investigations and outcomes among patients with type 2 myocardial infarction","volume":"107","author":"Kimenai","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.cpcardiol.2025.103148_bib0016","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijcard.2021.05.043","article-title":"Sex-based differences in clinical outcomes and resource utilization of type 2 myocardial infarction","volume":"338","author":"Ariss","year":"2021","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103148_bib0017","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/heartjnl-2014-306093","article-title":"TOTAL-AMI study group. Type 2 myocardial infarction in clinical practice","volume":"101","author":"Baron","year":"2015","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103148_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100795","article-title":"Sex differences in coronary artery disease characteristics among patients with type 2 myocardial infarction","volume":"3","author":"Lin","year":"2024","journal-title":"JACC. Adv."},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103148_bib0019","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41569-022-00769-8","article-title":"Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research","volume":"20","author":"Gaba","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103148_bib0020","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1056\/NEJMra2000317","article-title":"Atherosclerotic plaque healing","volume":"383","author":"Vergallo","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.cpcardiol.2025.103148_bib0021","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.jacc.2019.02.018","article-title":"Type 2 myocardial infarction","volume":"73","author":"Sandoval","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103148_bib0022","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1373\/clinchem.2016.255521","article-title":"Myocardial infarction type 2 and Myocardial injury","volume":"63","author":"Sandoval","year":"2017","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103148_bib0023","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1161\/01.CIR.100.5.559","article-title":"Ischemic preconditioning in humans: models, mediators, and clinical relevance","volume":"100","author":"Tomai","year":"1999","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103148_bib0024","first-page":"553","article-title":"How is cardiac troponin released from injured myocardium?","volume":"7","author":"Mair","year":"2018","journal-title":"Eur. Heart. J. Acute Cardiovasc. Care"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103148_bib0025","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.amjmed.2013.02.029","article-title":"Classification of myocardial infarction: frequency and features of type 2 myocardial infarction","volume":"126","author":"Saaby","year":"2013","journal-title":"Am. J. Med."},{"issue":"20","key":"10.1016\/j.cpcardiol.2025.103148_bib0026","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/CIRCULATIONAHA.119.040631","article-title":"Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury","volume":"140","author":"DeFilippis","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103148_bib0027","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/CIRCULATIONAHA.119.042960","article-title":"High-sensitivity cardiac troponin and the universal definition of myocardial infarction","volume":"141","author":"Chapman","year":"2020","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.cpcardiol.2025.103148_bib0028","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1161\/CIRCULATIONAHA.122.059454","article-title":"Zooming in on the enigmas of type 2 myocardial infarction","volume":"145","author":"White","year":"2022","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.cpcardiol.2025.103148_bib0029","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.3390\/jcm12196412","article-title":"Coronary artery disease: A key issue in type 2 myocardial infarction: systematic review and recent findings","volume":"12","author":"Yao","year":"2023","journal-title":"J. Clin. Med."},{"issue":"49","key":"10.1016\/j.cpcardiol.2025.103148_bib0030","doi-asserted-by":"crossref","first-page":"e9062","DOI":"10.1097\/MD.0000000000009062","article-title":"ST segment change and T wave amplitude ratio in lead aVR associated with coronary artery disease severity in patients with non-ST elevation myocardial infarction: a retrospective study","volume":"96","author":"\u0130\u00e7en","year":"2017","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103148_bib0031","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055755","article-title":"Diagnostic features, management and prognosis of type 2 myocardial infarction compared to type 1 myocardial infarction: a systematic review and meta-analysis","volume":"12","author":"White","year":"2022","journal-title":"BMJ Open."},{"issue":"17","key":"10.1016\/j.cpcardiol.2025.103148_bib0032","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jacc.2023.08.020","article-title":"Coronary computed tomographic angiography with fractional flow reserve in patients with type 2 myocardial infarction","volume":"82","author":"McCarthy","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103148_bib0033","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/emermed-2017-206869","article-title":"Characteristics and occurrence of type 2 myocardial infarction in emergency department patients: a prospective study","volume":"35","author":"Greenslade","year":"2018","journal-title":"Emerg. Med. J."},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103148_bib0034","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.20162","article-title":"Assessment of oxygen supply-demand imbalance and outcomes among patients with type 2 myocardial infarction: A secondary analysis of the high-STEACS cluster randomized clinical trial","volume":"5","author":"Bularga","year":"2022","journal-title":"JAMa Netw. Open."},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103148_bib0035","article-title":"Clinical characteristics, outcomes, and epidemiological trends of patients admitted with type 2 myocardial infarction","volume":"1","author":"Rogers","year":"2022","journal-title":"J. Soc. Cardiovasc. Angiogr. Interv."},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103148_bib0036","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11739-021-02920-8","article-title":"Type 2 myocardial infarction: a diagnostic and therapeutic challenge in contemporary cardiology","volume":"17","author":"Merlo","year":"2022","journal-title":"Intern. Emerg. Med."},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103148_bib0037","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.annemergmed.2024.11.019","article-title":"ECG patterns of occlusion myocardial infarction: A narrative review","volume":"85","author":"Ricci","year":"2025","journal-title":"Ann. Emerg. Med."},{"issue":"11","key":"10.1016\/j.cpcardiol.2025.103148_bib0038","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jacc.2008.12.016","article-title":"AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram","volume":"53","author":"Wagner","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cpcardiol.2025.103148_bib0039","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.resuscitation.2019.07.017","article-title":"Diagnostic value of lead aVR in electrocardiography for identifying acute coronary lesions in patients with out-of-hospital cardiac arrest","volume":"142","author":"Yamamoto","year":"2019","journal-title":"Resuscitation"},{"issue":"10","key":"10.1016\/j.cpcardiol.2025.103148_bib0040","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa1406761","article-title":"Clinical features and outcomes of Takotsubo (Stress) cardiomyopathy","volume":"373","author":"Templin","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103148_bib0041","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/CIRCULATIONAHA.121.054302","article-title":"Thresholds and kinetics to differentiate myocardial injury and myocardial infarction","volume":"144","author":"Wereski","year":"2021","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.cpcardiol.2025.103148_bib0042","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.amjmed.2017.05.049","article-title":"Type 1 and 2 myocardial infarction and myocardial injury: clinical transition to high-sensitivity cardiac troponin I","volume":"130","author":"Sandoval","year":"2017","journal-title":"Am. J. Med."},{"issue":"16","key":"10.1016\/j.cpcardiol.2025.103148_bib0043","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/CIRCULATIONAHA.120.046682","article-title":"Biomarkers enhance discrimination and prognosis of type 2 myocardial infarction","volume":"142","author":"Horiuchi","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103148_bib0044","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.119.043100","article-title":"Incidence, trends, and outcomes of type 2 myocardial infarction in a community cohort","volume":"141","author":"Raphael","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103148_bib0045","first-page":"317","article-title":"Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180-day mortality risk","volume":"3","author":"Sandoval","year":"2014","journal-title":"Eur. Heart. J. Acute Cardiovasc. Care"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103148_bib0046","first-page":"62","article-title":"Direct comparison of high-sensitivity cardiac troponin T and I in the early differentiation of type 1 vs. type 2 myocardial infarction","volume":"11","author":"Nestelberger","year":"2022","journal-title":"Eur. Heart. J. Acute Cardiovasc. Care"},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103148_bib0047","first-page":"355","article-title":"Differences between cardiac troponin I vs. T according to the duration of myocardial ischaemia","volume":"12","author":"Espinosa","year":"2023","journal-title":"Eur. Heart. J. Acute Cardiovasc. Care"},{"issue":"11","key":"10.1016\/j.cpcardiol.2025.103148_bib0048","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1161\/CIRCULATIONAHA.120.046574","article-title":"Temporal release of high-sensitivity cardiac troponin T and I and copeptin after brief induced coronary artery balloon occlusion in humans","volume":"143","author":"\u00c1rnad\u00f3ttir","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2025.103148_bib0049","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/jlpm-23-40","article-title":"Cardiac troponin and the diagnosis of type 2 myocardial infarction and acute non-ischaemic myocardial injury","volume":"9","author":"Taggart","year":"2024","journal-title":"J. Lab. Precis. Med."},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103148_bib0050","first-page":"718","article-title":"How is cardiac troponin released from cardiomyocytes?","volume":"11","author":"Hammarsten","year":"2022","journal-title":"Eur. Heart. J. Acute Cardiovasc. Care"},{"issue":"10","key":"10.1016\/j.cpcardiol.2025.103148_bib0051","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/clinchem\/hvae110","article-title":"Diagnosing myocardial injury in an acute chest pain cohort; long-term prognostic implications of cardiac troponin T and I","volume":"70","author":"Saeed","year":"2024","journal-title":"Clin. Chem."},{"issue":"19","key":"10.1016\/j.cpcardiol.2025.103148_bib0052","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.jacc.2023.08.048","article-title":"Cardiac troponin assays to distinguish between acute and chronic myocardial injury","volume":"82","author":"S\u00f6rensen","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.cpcardiol.2025.103148_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276645","article-title":"Diagnostic and prognostic performance of the ratio between high-sensitivity cardiac troponin I and troponin T in patients with chest pain","volume":"17","author":"Eggers","year":"2022","journal-title":"PLoS. One"},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103148_bib0054","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1373\/clinchem.2018.301127","article-title":"Full-size and partially truncated cardiac troponin complexes in the blood of patients with acute myocardial infarction","volume":"65","author":"Vylegzhanina","year":"2019","journal-title":"Clin. Chem."},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103148_bib0055","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1373\/clinchem.2012.200543","article-title":"Time-dependent degradation pattern of cardiac troponin T following myocardial infarction","volume":"59","author":"Cardinaels","year":"2013","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103148_bib0056","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bja.2023.12.017","article-title":"Pathophysiological mechanisms underlying increased circulating cardiac troponin in noncardiac surgery: a narrative review","volume":"132","author":"Bollen Pinto","year":"2024","journal-title":"Br. J. Anaesth."},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103148_bib0057","first-page":"52","article-title":"Peptidic Connexin43 therapeutics in Cardiac reparative medicine","volume":"8","author":"Marsh","year":"2021","journal-title":"J. Cardiovasc. Dev. Dis."},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103148_bib0058","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cell.2020.08.031","article-title":"A network of macrophages supports mitochondrial homeostasis in the heart","volume":"183","author":"Nicol\u00e1s-\u00c1vila","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103148_bib0059","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2024-002954","article-title":"Composition of cardiac troponin release differs after marathon running and myocardial infarction","volume":"11","author":"Airaksinen","year":"2024","journal-title":"Open. Heart."},{"issue":"18","key":"10.1016\/j.cpcardiol.2025.103148_bib0060","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1161\/CIRCULATIONAHA.122.060845","article-title":"Novel troponin fragmentation assay to discriminate between troponin elevations in acute myocardial infarction and end-stage renal disease","volume":"146","author":"Airaksinen","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2025.103148_bib0061","first-page":"zuae115","article-title":"Novel troponin fragmentation assay to discriminate between Takotsubo syndrome and acute myocardial infarction","author":"Airaksinen","year":"2024","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103148_bib0062","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1373\/clinchem.2017.286211","article-title":"Full-size cardiac troponin I and its proteolytic fragments in blood of patients with acute myocardial infarction: antibody selection for assay development","volume":"64","author":"Katrukha","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cpcardiol.2025.103148_bib0063","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.clinbiochem.2019.06.012","article-title":"Cardiac troponin I is present in plasma of type 1 myocardial infarction patients and patients with troponin I elevations due to other etiologies as complex with little free I","volume":"73","author":"Van Wijk","year":"2019","journal-title":"Clin. Biochem."},{"issue":"12","key":"10.1016\/j.cpcardiol.2025.103148_bib0064","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.3390\/jcm8122100","article-title":"Type 1 or Type 2 myocardial infarction in patients with a history of coronary artery disease: data from the Emergency Department","volume":"8","author":"Putot","year":"2019","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103148_bib0065","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/jamacardio.2021.0669","article-title":"Cardiovascular biomarkers in the early discrimination of type 2 myocardial infarction","volume":"6","author":"Nestelberger","year":"2021","journal-title":"JAMa Cardiol."},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103148_bib0066","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jacc.2013.04.011","article-title":"Copeptin helps in the early detection of patients with acute myocardial infarction","volume":"62","author":"Maisel","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103148_bib0067","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.amjmed.2015.06.033","article-title":"Ultra-sensitive copeptin and cardiac troponin in diagnosing non-ST-segment elevation acute coronary syndromes\u2014The COPACS study","volume":"129","author":"Ricci","year":"2016","journal-title":"Am. J. Med."},{"issue":"8","key":"10.1016\/j.cpcardiol.2025.103148_bib0068","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jacc.2021.06.027","article-title":"A biomarker model to distinguish types of myocardial infarction and injury","volume":"78","author":"Neumann","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cpcardiol.2025.103148_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.131879","article-title":"Copeptin for the differentiation of type 1 versus type 2 myocardial infarction or myocardial injury","volume":"403","author":"Kassem","year":"2024","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103148_bib0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.ATV.0000251503.35795.4f","article-title":"Biomarkers of atherosclerotic plaque instability and rupture","volume":"27","author":"Koenig","year":"2007","journal-title":"Arter. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.cpcardiol.2025.103148_bib0071","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.3390\/life13101992","article-title":"Novel biomarkers and their role in the diagnosis and prognosis of acute coronary syndrome","volume":"13","author":"Katsioupa","year":"2023","journal-title":"Life"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103148_bib0072","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/CIRCRESAHA.116.309955","article-title":"Novel risk markers and risk assessments for cardiovascular disease","volume":"120","author":"Thomas","year":"2017","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103148_bib0073","doi-asserted-by":"crossref","DOI":"10.2174\/1573403X18666220411113450","article-title":"Synopsis of biomarkers of atheromatous plaque formation, rupture and thrombosis in the diagnosis of acute coronary syndromes","volume":"18","author":"Udaya","year":"2022","journal-title":"Curr. Cardiol. Rev."},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103148_bib0074","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1538-7836.2010.04162.x","article-title":"Thrombin generation in patients with a first acute myocardial infarction","volume":"9","author":"Smid","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.cpcardiol.2025.103148_bib0075","series-title":"Advances in Clinical Chemistry [Internet]","doi-asserted-by":"crossref","DOI":"10.1016\/S0065-2423(10)51001-1","article-title":"Prothrombin Fragments in Cardiovascular Disease","author":"P\u00e1ramo","year":"2010"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103148_bib0076","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1076029607309176","article-title":"Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis","volume":"14","author":"Ota","year":"2008","journal-title":"Clin. Appl. Thromb."},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103148_bib0077","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ahj.2003.07.015","article-title":"Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st\u2013segment elevation myocardial infarction","volume":"147","author":"Gy\u00f6ngy\u00f6si","year":"2004","journal-title":"Am. Heart. J."},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103148_bib0078","first-page":"343","article-title":"Biomarkers of coagulation and fibrinolysis in acute myocardial infarction: a joint position paper of the association for acute cardiovascular care and the european society of cardiology working group on thrombosis","volume":"10","author":"Krychtiuk","year":"2021","journal-title":"Eur. Heart. J. Acute Cardiovasc. Care"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103148_bib0079","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/cells9010231","article-title":"Neutrophil extracellular traps and cardiovascular diseases: an update","volume":"9","author":"Bonaventura","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.cpcardiol.2025.103148_bib0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.thromres.2022.03.002","article-title":"Neutrophil extracellular traps (NETs) in patients with STEMI. Association with percutaneous coronary intervention and antithrombotic treatments","volume":"213","author":"Ferr\u00e9-Vallverd\u00fa","year":"2022","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103148_bib0081","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00395-019-0740-3","article-title":"Neutrophil extracellular traps and fibrocytes in ST-segment elevation myocardial infarction","volume":"114","author":"Hofbauer","year":"2019","journal-title":"Basic Res. Cardiol."},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103148_bib0082","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52671-y","article-title":"Neutrophil extracellular traps and monocyte subsets at the culprit lesion site of myocardial infarction patients","volume":"9","author":"Mangold","year":"2019","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.cpcardiol.2025.103148_bib0083","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3390\/biomedicines10081850","article-title":"Neutrophils and neutrophil extracellular traps in cardiovascular disease: an overview and potential therapeutic approaches","volume":"10","author":"Shirakawa","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103148_bib0084","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12950-023-00344-z","article-title":"Neutrophil extracellular traps in acute coronary syndrome","volume":"20","author":"Wu","year":"2023","journal-title":"J. Inflamm."},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103148_bib0085","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/jcm10061264","article-title":"External validation and extension of a clinical score for the discrimination of type 2 myocardial infarction","volume":"10","author":"Nestelberger","year":"2021","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103148_bib0086","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.amjmed.2018.10.022","article-title":"Risk estimation in type 2 myocardial infarction and myocardial injury: the TARRACO Risk score","volume":"132","author":"Cediel","year":"2019","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103148_bib0087","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jacc.2019.11.004","article-title":"Application of the GRACE, TIMI, and TARRACO risk scores in type 2 myocardial infarction","volume":"75","author":"Murphy","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cpcardiol.2025.103148_bib0088","unstructured":"Hung J, Roos A, Kadesjo E, et al. Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction."},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103148_bib0089","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jacc.2022.10.025","article-title":"Improving risk stratification for patients with type 2 myocardial infarction","volume":"81","author":"Taggart","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.cpcardiol.2025.103148_bib0090","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/CIRCULATIONAHA.121.058542","article-title":"Coronary artery and cardiac disease in patients with type 2 myocardial infarction: a prospective cohort study","volume":"145","author":"Bularga","year":"2022","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103148_bib0091","first-page":"253","article-title":"L\u2019ecocardiografia speckle tracking: roadmap per la misurazione e l\u2019utilizzo clinico [Speckle tracking echocardiography: a practical guide]","volume":"18","author":"Cameli","year":"2017","journal-title":"G. Ital. Cardiol."},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103148_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2019.03.007","article-title":"Speckle tracking echocardiography in non\u2013ST-segment elevation acute coronary syndromes","volume":"46","author":"Mele","year":"2021","journal-title":"Curr. Probl. Cardiol."},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103148_bib0093","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12574-022-00568-7","article-title":"Novel regional longitudinal strain by speckle tracking to detect significant coronary artery disease in patients admitted to the emergency department for chest pain suggestive of acute coronary syndrome","volume":"20","author":"Norum","year":"2022","journal-title":"J. Echocardiogr."},{"issue":"19","key":"10.1016\/j.cpcardiol.2025.103148_bib0094","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.3390\/jcm10194521","article-title":"Myocardial work by echocardiography: principles and applications in clinical practice","volume":"10","author":"Ilardi","year":"2021","journal-title":"J. Clin. Med."},{"issue":"8","key":"10.1016\/j.cpcardiol.2025.103148_bib0095","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.echo.2019.02.014","article-title":"Global myocardial work is superior to Global longitudinal strain to predict significant coronary artery disease in patients with normal left ventricular function and wall motion","volume":"32","author":"Edwards","year":"2019","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"11","key":"10.1016\/j.cpcardiol.2025.103148_bib0096","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/ehjci\/jev078","article-title":"Non-invasive myocardial work index identifies acute coronary occlusion in patients with non-ST-segment elevation-acute coronary syndrome","volume":"16","author":"Boe","year":"2015","journal-title":"Eur. Heart J. \u2013 Cardiovasc. Imag."},{"key":"10.1016\/j.cpcardiol.2025.103148_bib0097","article-title":"Regional myocardial work measured by echocardiography for the detection of myocardial ischemic segments: A comparative study with invasive fractional flow reserve","volume":"9","author":"Guo","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103148_bib0098","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/ehjci\/jeae110","article-title":"Tricuspid annular plane systolic excursion over systolic pulmonary artery pressure prognostic value for in-hospital adverse events in patients hospitalized for acute coronary syndrome","volume":"25","author":"Fauvel","year":"2024","journal-title":"Eur. Heart J. - Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103148_bib0099","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jcmg.2012.09.016","article-title":"Napkin-ring sign on coronary CT angiography for the prediction of acute coronary syndrome","volume":"6","author":"Otsuka","year":"2013","journal-title":"JACC. Cardiovasc. ImAging"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103148_bib0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jacc.2015.05.069","article-title":"Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up","volume":"66","author":"Motoyama","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"18","key":"10.1016\/j.cpcardiol.2025.103148_bib0101","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.119.044720","article-title":"Low-attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: results from the Multicenter SCOT-HEART trial (Scottish Computed Tomography of the HEART)","volume":"141","author":"Williams","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103148_bib0102","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4244\/EIJ-D-24-00779","article-title":"Usefulness of FFR-CT to exclude haemodynamically significant lesions in high-risk NSTE-ACS","volume":"21","author":"Meier","year":"2025","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103148_bib0103","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12933-020-01019-2","article-title":"Cardiac magnetic resonance for asymptomatic patients with type 2 diabetes and cardiovascular high risk (CATCH): a pilot study","volume":"19","author":"Ng","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"issue":"22","key":"10.1016\/j.cpcardiol.2025.103148_bib0104","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.jacc.2024.03.419","article-title":"Coronary atherosclerotic plaque activity and risk of myocardial infarction","volume":"83","author":"Wang","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.cpcardiol.2025.103148_bib0105","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamacardio.2023.1729","article-title":"Coronary atherosclerotic plaque activity and future Coronary events","volume":"8","author":"Moss","year":"2023","journal-title":"JAMa Cardiol."},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103148_bib0106","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.amjmed.2015.11.035","article-title":"Impact on long-term mortality of presence of obstructive coronary artery disease and classification of myocardial infarction","volume":"129","author":"Baron","year":"2016","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cpcardiol.2025.103148_bib0107","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjcard.2021.02.011","article-title":"Sex-based differences in prevalence and outcomes of common acute conditions associated with type 2 myocardial infarction","volume":"147","author":"MO","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cpcardiol.2025.103148_bib0108","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ajem.2021.03.042","article-title":"Revascularization rates with coronary angioplasty and mortality in type 2 myocardial infarction: A meta-regression analysis","volume":"47","author":"Mele","year":"2021","journal-title":"Am. J. Emerg. Med."},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103148_bib0109","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3390\/jcm12062129","article-title":"Role of intracoronary imaging in myocardial infarction with non-obstructive coronary disease (MINOCA): A review","volume":"12","author":"Borzillo","year":"2023","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103148_bib0110","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3390\/jcm11051361","article-title":"Detection of vulnerable coronary plaques using invasive and non-invasive imaging modalities","volume":"11","author":"Van Veelen","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cpcardiol.2025.103148_bib0111","doi-asserted-by":"crossref","first-page":"jeab028","DOI":"10.1093\/ehjci\/jeab028","article-title":"Optical coherence tomography detection of vulnerable plaques at high risk of developing acute coronary syndrome","author":"Kubo","year":"2021","journal-title":"Eur Heart J - Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103148_bib0112","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jjcc.2015.04.001","article-title":"Type 2 myocardial infarction: A descriptive analysis and comparison with type 1 myocardial infarction","volume":"67","author":"Landes","year":"2016","journal-title":"J. Cardiol."},{"key":"10.1016\/j.cpcardiol.2025.103148_bib0113","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ahj.2018.09.016","article-title":"The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design","volume":"208","author":"Lambrakis","year":"2019","journal-title":"Am. Heart. J."},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103148_bib0114","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/eurheartj\/ehae803","article-title":"Type 2 myocardial infarction: challenges in diagnosis and treatment","volume":"46","author":"Chapman","year":"2025","journal-title":"Eur. Heart. J."},{"issue":"26","key":"10.1016\/j.cpcardiol.2025.103148_bib0115","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1056\/NEJMoa2307983","article-title":"Restrictive or liberal transfusion strategy in myocardial infarction and anemia","volume":"389","author":"Carson","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.cpcardiol.2025.103148_bib0116","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.3390\/jcm12196412","article-title":"Coronary artery disease: A key issue in type 2 myocardial infarction: systematic review and recent findings","volume":"12","author":"Yao","year":"2023","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103148_bib0117","first-page":"523","article-title":"Infarto miocardico di tipo 2: aspetti diagnostici, terapeutici e prognostici [Diagnostic, therapeutic and prognostic aspects of type 2 myocardial infarction]","volume":"23","author":"Santucci","year":"2022","journal-title":"G. Ital. Cardiol. (Rome)"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103148_bib0118","doi-asserted-by":"crossref","first-page":"26","DOI":"10.17925\/HI.2021.15.1.26","article-title":"Dual antiplatelet therapy in patients with high cardiovascular risk","volume":"15","author":"Espinoza","year":"2021","journal-title":"Heart. Int."},{"issue":"33","key":"10.1016\/j.cpcardiol.2025.103148_bib0119","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1093\/eurheartj\/ehz299","article-title":"Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial","volume":"40","author":"White","year":"2019","journal-title":"Eur. Heart. J."},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103148_bib0120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12933-024-02328-6","article-title":"Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trial","volume":"23","author":"Fitchett","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103148_bib0121","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/ehjcvp\/pvae006","article-title":"Effects of albiglutide on myocardial infarction and ischaemic heart disease outcomes in patients with type 2 diabetes and cardiovascular disease in the Harmony Outcomes trial","volume":"10","author":"Krychtiuk","year":"2024","journal-title":"Eur. Heart J. - Cardiovasc. Pharmacother."},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103148_bib0122","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.amjmed.2013.12.020","article-title":"Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort","volume":"127","author":"Saaby","year":"2014","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103148_bib0123","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jacc.2021.05.026","article-title":"Causes of death after type 2 myocardial infarction and myocardial injury","volume":"78","author":"Raphael","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.cpcardiol.2025.103148_bib0124","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1136\/heartjnl-2023-322463","article-title":"Association between troponin level and medium-term mortality in 20 000 hospital patients","volume":"109","author":"Hinton","year":"2023","journal-title":"Heart."},{"key":"10.1016\/j.cpcardiol.2025.103148_bib0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.amjcard.2021.07.013","article-title":"Characteristics and outcomes of patients admitted with type 2 myocardial infarction","volume":"157","author":"Tripathi","year":"2021","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103148_bib0126","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jacc.2019.12.052","article-title":"Cardiovascular mortality after type 1 and type 2 myocardial infarction in young adults","volume":"75","author":"Singh","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103148_bib0127","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jamacardio.2024.0127","article-title":"Type 2 myocardial infarction\u2014Poorly understood, underevaluated, and too often ignored","volume":"9","author":"De Lemos","year":"2024","journal-title":"JAMa Cardiol."}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280625001689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280625001689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T17:05:50Z","timestamp":1756832750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280625001689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":127,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0146280625001689"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2025.103148","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting type 2 myocardial infarction: Unmet clinical needs","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2025.103148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103148"}}